{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Yeruham",
      "state": "N/A",
      "country": "Israel",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "71765",
      "recalling_firm": "Perrigo Israel Pharmaceuticals",
      "address_1": "1 Zvi Bornstein Rd",
      "address_2": "N/A",
      "postal_code": "N/A",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide and Puerto Rico",
      "recall_number": "D-1286-2015",
      "product_description": "Mometasone Furoate Ointment USP, 0.1%, 15 g tubes, Rx Only, Manufactured by Perrigo, Yeruham 80500, Israel, Distributed by Perrigo, Allegan, MI 49010, NDC 45802-0119-37",
      "product_quantity": "158,268 tubes",
      "reason_for_recall": "Subpotent drug",
      "recall_initiation_date": "20150713",
      "center_classification_date": "20150805",
      "termination_date": "20160211",
      "report_date": "20150812",
      "code_info": "Lot # 063630, Exp 04/16; 069793, Exp 11/16; 071745, Exp 02/17; 076150, Exp 07/17; 081317, Exp 12/17"
    }
  ]
}